-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Tracy Cooley
Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.
Latest Posts
Celebrating the Overlooked Origin of a Miracle Vaccine
Ever heard of Maurice Hilleman? Chances are that you haven’t, but he may be responsible for saving your life and the life of your kids and grand kids. Hilleman truly is one of the unsung heroes of the vaccines industry. He invented the measles vaccine estimated to have saved at least 100 million lives. Today, 95 percent of children in the U.S. receive the MMR — the vaccine for measles, mumps and rubella invented by Read More >
Dr. Paul Offit Asks “Do you Believe in Magic?”
In his new book released today – Do You Believe in Magic? - Paul A. Offit, M.D., exposes the facts behind the alternative medicine ind ustry. The book details how alternative medicine-an unregulated industry under no legal obligation to prove its claims or admit its risks-can actually be harmful to public health. Through real-life stories, Dr. Offit separates fact from fiction and provides examples of nontraditional methods that can be beneficial, in some cases exceeding therapies Read More >
National Patient Advocate Foundation: Cancer Patients are Being Left Behind
Roll Call published a commentary today by Nancy Davenport-Ennis of the National Patient Advocate Foundation on the effects of the sequester on cancer care. The op ed states that these ‘cuts are shown to directly impact patients through higher copayments, longer travel times and increased travel expenses, visits to multiple providers and locations for care and services, and delays seeking treatment even as cancer progresses.’ Despite these facts, some have called for even deeper cuts Read More >
Moving Inside the Beltway: Brief Health Roundup
We are working to move the following legislation forward: Immigration: S. 744, The Border Security, Economic Opportunity, and Immigration Modernization Act, includes provisions that would ensure employers with greater access to U.S.-trained immigrant scientists and engineers, and we are working to ensure that remains the case. As drafted, S. 744 would raise the cap on H-1B visas from 65,000 to 110,000, with an option to elevate the cap up to 180,000 based on market demand Read More >
SBIR Reauthorization Moves Forward
NIH has reissued its Small Business Innovation Research (SBIR) Omnibus Grant Solicitation announcement, which states that small businesses that are majority-owned by multiple venture capital operating companies are eligible to apply for (1) these SBIR grants and (2) any other NIH SBIR funding opportunities announced after January 28, 2013. The NIH grant solicitation announcement can be found here. With this re-issuance, small businesses that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds Read More >
